Navigation Links
Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
Date:10/25/2010

EAST BRUNSWICK, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Company will host a conference call on Tuesday, October 26, 2010 at 8:30 a.m. Eastern Time during which it will provide further detail around its KRYSTEXXA™ launch plans.

Conference Call Information

Savient's management team will host a live conference call on October 26, 2010 at 8:30 a.m. Eastern Time. To participate by telephone, please dial (888) 357-3694 (Domestic) or (973) 890-8276 (International).  The conference identification number is 20949091.  The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com.  Please log on to Savient's website fifteen minutes prior to the start of the call to ensure adequate time for any downloads that may be necessary.

A telephone replay will be available from 12:00 p.m. Eastern Time on October 26, 2010 through 11:59 p.m. Eastern Time on November 2, 2010 by dialing (800) 642-1687 (Domestic) or (706) 645-9291 (International) and entering conference ID number 20949091.

About Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA™ (pegloticase), which was approved by the FDA on September 14, 2010 for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents dis
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Grammy Award-winner Bruce Hornsby will ... philanthropists, athletes, actors, and musicians during the 10 th ... at the Mandarin Oriental Hotel in New ... honor six individuals who embody the values of the ... its highest honor, the Spirit of an Active Lifestyle ...
(Date:10/31/2014)... Imago BioSciences, Inc., a biotech company ... Series A financing led by Clarus Ventures LLC, ... of accomplished investment and operating professionals dedicated to ... include Frazier Healthcare, Amgen Ventures, and Merck Research ... Frazier Healthcare will join the company,s board of ...
(Date:10/31/2014)... Investor-Edge has initiated coverage on ... ), Isis Pharmaceuticals Inc. (NASDAQ: ISIS ), ... Pharmaceuticals Inc. (NASDAQ: ACAD ), and Synta ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,566.14, up 0.37%, the Dow Jones Industrial ...
Breaking Medicine Technology:10th Anniversary Orthopaedic Foundation Gala Set For Success 2Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a ... extracellular matrix , today announced it plans to report ... 2011 before the open of the financial markets. The ... the investment community at 8:00 a.m. PDT (11:00 a.m. ...
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader ... and infectious diseases, announced today that the company will make ... Research Conference San Francisco, CA, May 9-11, 2011 The ... Dr. J. Joseph Kim, Ph.D., President & CEO May 9, ...
Cached Medicine Technology:Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6 2Inovio Pharmaceuticals to Present at Investor Conferences 2Inovio Pharmaceuticals to Present at Investor Conferences 3Inovio Pharmaceuticals to Present at Investor Conferences 4
(Date:10/31/2014)... Chico, CA. (PRWEB) October 31, 2014 ... best known for its small scale BioPro™ biodiesel ... equipment that will further improve the performance and ... , The GL95/MC12/BD380 trio will recover ... is mixed in with the glycerin by-product produced ...
(Date:10/31/2014)... Research Center for Healthy Neighborhoods (PRCHN) at Case ... key player in nearly $13.32 million in federal ... Ohio. , The Centers for Disease Control and ... million over five years. The funds will support ... disseminating individual, environmental, and policy interventions that prevent ...
(Date:10/31/2014)... Colorado (PRWEB) October 31, 2014 The Memory ... was created by Alexander Lynch, whose father suffered from Alzheimer's ... a dramatic moment, caused by his father's disease. His father ... That was the crucial moment when the author of this ... his dad. , The Memory Healer program is based ...
(Date:10/31/2014)... 2014 Monica Williams-Murphy MD , ... too well the chaos that can occur for people ... vast majority of Americans who come into the emergency ... completely unprepared for the moment and so are their ... serve as a catalyst for a family to get ...
(Date:10/31/2014)... Summit, Missouri (PRWEB) October 31, 2014 ... the country about families narrowly escaping carbon monoxide poisoning ... season) looms just weeks away, one family-owned, Missouri-based heating ... straightforward approach to making sure families start the home ... are safe and secure. , Beginning Nov. 1, ...
Breaking Medicine News(10 mins):Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3
... at the Imperial College London it was found that lab ... , It was believed that early exposure to ... lab workers who frequently handled research rodents had fewer allergic ... to be protective against eczema allergy. The study results are ...
... a stroke, caused either by a blocked or burst blood vessel ... die. ,That's the bad news. ,And the good news! ... problems that cause many strokes — before a stroke ever happens. ... the skull. ,New technologies, delivered to the brain via ...
... who is now 42 years old has been slightly unconscious and ... His nerves were completely sheared in a car crash and he ... others by means of grunts and nods. But now his speech ... the tiny nerve connections in his brain slowly started to rewire. ...
... conducted by the Korean scientists from the Korea Research Institute of ... that the research team has found a human gene that aids ... The researchers were very happy about the discovery and said that ... cancers. ,The study was mainly conducted on mice and ...
... Haryana Government has decided to start a two year ... in Panchakarma at Shri Krishna Government// Ayurvedic College at ... diploma courses has already been formulated and these courses ... state Health Minister Kartar Devi told reporters here., ...
... to be far from the goal of any reversal of the ... in cases of drug abuse in all of Europe//. The statistics ... abuse category and a rank 3 in cocaine and ecstasy abuse. ... abuse. ,As per the drug policy of the government, ...
Cached Medicine News:Health News:Brain Surgery Without the Surgery? 2Health News:Brain Surgery Without the Surgery? 3Health News:Brain Surgery Without the Surgery? 4Health News:Brain Surgery Without the Surgery? 5Health News:Brain Surgery Without the Surgery? 6
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... The Bio-Rad Mumps IgG test is an ... Test results are obtained after a 90-minute incubation. ... index values, permitting uniformity of reporting. The ... qualitative and semi-quantitative detection of human IgG antibodies ...
... Bio-Rad Measles IgG test is an enzyme immunoassay ... are obtained after a 90-minute incubation. The ... permitting uniformity of results. The Bio-Rad Measles ... semi-quantitative detection of human IgG antibodies to measles ...
Medicine Products: